anti-Advanced Glycosylation End Product-Specific Receptor (AGER) 抗体产品概述

Full name:
anti-Advanced Glycosylation End Product-Specific Receptor 抗体 (AGER)
在www.antibodies-online.cn可供308 Advanced Glycosylation End Product-Specific Receptor (AGER) 抗体的30不同的供货商。 再加上,我们可以发Advanced Glycosylation End Product-Specific Receptor 试剂盒 (81)Advanced Glycosylation End Product-Specific Receptor 蛋白 (40)和数多这个蛋白质的别的产品。 总共446 Advanced Glycosylation End Product-Specific Receptor产品已列进来了。
别名:
AGER, RAGE
列出全部抗体 基因 基因ID UniProt
AGER 177 Q15109
AGER 11596  
AGER 81722  

显示所有的来源

显示所有的同义词

最受欢迎的抗anti-Advanced Glycosylation End Product-Specific Receptor (AGER) 抗体

选择您的来源和应用

抗Human 抗体:

抗Mouse (Murine) 抗体:

抗Rat (Rattus) 抗体:

所有可销售的anti-Advanced Glycosylation End Product-Specific Receptor 抗体

您会转到已过滤好的搜索

引用最多的anti-Advanced Glycosylation End Product-Specific Receptor 抗体

  1. Rat (Rattus) Polyclonal AGER Primary Antibody for FACS, IF (p) - ABIN725900 : Huang, Yao, Zhang, Dong, Yu, Sheng: The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats. in Shock (Augusta, Ga.) 2009 (PubMed)
    Show all 5 references for 725900

  2. Human Polyclonal AGER Primary Antibody for IHC (p), WB - ABIN389027 : Schlueter, Hauke, Flohr, Rogalla, Bullerdiek: Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing? in Biochimica et biophysica acta 2003 (PubMed)
    Show all 4 references for 389027

  3. Human Polyclonal AGER Primary Antibody for IF, IHC (p) - ABIN1108826 : Bierhaus, Haslbeck, Humpert, Liliensiek, Dehmer, Morcos, Sayed, Andrassy, Schiekofer, Schneider, Schulz, Heuss, Neundörfer, Dierl, Huber, Tritschler, Schmidt, Schwaninger, Haering, Schleicher, Kasper et al.: Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. ... in The Journal of clinical investigation 2004 (PubMed)
    Show all 4 references for 1108826

  4. Human Polyclonal AGER Primary Antibody for EIA, IHC (p) - ABIN357685 : Shanmugam, Kim, Lanting, Natarajan: Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. in The Journal of biological chemistry 2003 (PubMed)
    Show all 3 references for 357685

  5. Cow (Bovine) Polyclonal AGER Primary Antibody for WB - ABIN2786877 : Luo, Saiardi, Nagata, Ye, Yu, Jung, Luo, Jain, Sawa, Snyder: GRAB: a physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase. in Neuron 2001 (PubMed)
    Show all 2 references for 2786877

  6. Human Polyclonal AGER Primary Antibody for EIA, IHC (p) - ABIN359696 : Miyata, Akashi, Nishida: Molecular cloning and characterization of a novel member of the MAP kinase superfamily. in Genes to cells : devoted to molecular & cellular mechanisms 1999 (PubMed)
    Show all 2 references for 359696

  7. Cow (Bovine) Polyclonal AGER Primary Antibody for WB - ABIN2776831 : Galichet, Weibel, Heizmann: Calcium-regulated intramembrane proteolysis of the RAGE receptor. in Biochemical and biophysical research communications 2008 (PubMed)

  8. Human Polyclonal AGER Primary Antibody for IF, WB - ABIN390897 : Peng, Lu, Wang, Yan, Chen, Zhang, Zhang, Shen: RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. in Archives of medical research 2009 (PubMed)

  9. Human Polyclonal AGER Primary Antibody for IHC, WB - ABIN2776917 : Lieuw-a-Fa, Schalkwijk, Engelse, van Hinsbergh: Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs. in Thrombosis and haemostasis 2006 (PubMed)

更多抗Advanced Glycosylation End Product-Specific Receptor的相互作用对抗体

Human Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. There was no significant difference in plasma levels of sRAGE or HMGB1 (显示 HMGB1 抗体) between pAPS (显示 PAPSS1 抗体) patients and HCs (显示 HLCS 抗体). Plasma levels of sRAGE/HMGB1 (显示 HMGB1 抗体) could not be utilized to differentiate between APA (显示 ENPEP 抗体)+SLE and APS (显示 SH2B2 抗体)+SLE patients

  2. Ligand-induced association of RAGE homodimers on the cell surface increases the molecular dimension of the receptor, recruiting DIAPH1 (显示 DIAPH1 抗体) and activating signaling pathways.

  3. AGER polymorphisms showed no statistically significant difference between patients with primary open-angle glaucoma and healthy controls.

  4. Our findings demonstrate how RAGE-PR3 interactions between human prostate cancer cells and the bone marrow microenvironment mediate bone metastasis during prostate cancer progression

  5. The severity of acute respiratory distress syndrome in preterm infants seemed to be associated with the plasma level of sRAGE and AQP5 (显示 AQP5 抗体): the more severe the disease, the higher the plasma level of sRAGE and AQP5 (显示 AQP5 抗体)

  6. Advanced glycation end products are capable of inducing VEGF (显示 VEGFA 抗体) production and inflammatory responses via RAGE-NF-kappaB (显示 NFKB1 抗体) pathway activation in synoviocytes.

  7. Atrial tissue expression of RAGE was significantly associated with atrial fibrosis in patients with mitral valve disease.

  8. RAGE drives tumor progression and metastasis through distinct tumor cell-intrinsic and -extrinsic mechanisms, and may represent a novel and therapeutically viable approach for treating metastatic cancers.

  9. these studies suggest that expression of RAGE in T cells of patients at risk for type 1 diabetes progressing to disease predates dysglycemia

  10. These studies confirm that intranasal insulin (显示 INS 抗体) improves indexes of experimental DPN but indicates that females with DPN may differ in their underlying phenotype. RN mice had partial but incomplete protection from underlying DPN and lesser impacts from insulin (显示 INS 抗体).

Cow (Bovine) Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. Our results suggested that the increased RAGE expression in inflammatory circumstances and interaction with AGEs are risk factors in decreasing of aggrecan (显示 ACAN 抗体) content in nucleus pulposus.

Mouse (Murine) Advanced Glycosylation End Product-Specific Receptor (AGER) interaction partners

  1. perturbation of Bone marrow mesenchymal stromal cells in diabetes mellitus could be partially explained by chronic RAGE signaling.

  2. RAGE mediates inflammation that contributes to lung damage, in cigarette smoke-induced lung pathology.

  3. Ager deletion enhances ischemic muscle inflammation, angiogenesis, and blood flow recovery in diabetic mice.

  4. HMGB1 (显示 HMGB1 抗体) neither exerts influence on cardiac remodeling by binding to RAGE nor induces apoptosis of cardiomyocytes under physiological condition

  5. Our results indicate that lack of RAGE has no significant impact on septic arthritis. However, RAGE-/- mice had significantly higher BMD (显示 BEST1 抗体) compared to WT mice, which coincided with lower IL-17A (显示 IL17A 抗体) in RAGE-/- mice. In sepsis, RAGE deficiency impairs bacterial kidney clearance.

  6. SAA (显示 SAA1 抗体) is a potential new uremic toxin involved in uremia-related atherosclerosis through interaction with RAGE.

  7. that selective RAGE regulation reflects a self-protective mechanism to maintain low levels of RAGE ligands

  8. Data show that receptor for advanced glycation end products (RAGE) impairs collateral growth in a diabetic setting and also in a non-diabetic setting, indicting the importance of RAGE and alternate RAGE ligands in the setting of collateral vessel growth.

  9. These findings demonstrate the role for RAGE-dependent IL-10 (显示 IL10 抗体) suppression as a key modulator of mortality from Gram-negative sepsis.

  10. HMGB1 (显示 HMGB1 抗体) promotes intraoral palatal wound healing through RAGE-dependent mechanisms.

Advanced Glycosylation End Product-Specific Receptor (AGER) 抗原简介

Antigen Summary

The advanced glycosylation end product (AGE) receptor encoded by this gene is a member of the immunoglobulin superfamily of cell surface receptors. It is a multiligand receptor, and besides AGE, interacts with other molecules implicated in homeostasis, development, and inflammation, and certain diseases, such as diabetes and Alzheimer's disease. Many alternatively spliced transcript variants encoding different isoforms, as well as non-protein-coding variants, have been described for this gene (PMID:18089847).

Alternative names and synonyms associated with Advanced Glycosylation End Product-Specific Receptor (AGER)

  • advanced glycosylation end product-specific receptor (AGER) 抗体
  • advanced glycosylation end product-specific receptor (Ager) 抗体
  • advanced glycosylation end product-specific receptor (LOC100343142) 抗体
  • AGER 抗体
  • RAGE 抗体

Protein level used designations for AGER

advanced glycosylation end product-specific receptor , RAGE isoform NtRAGE-delta , RAGE isoform sRAGE-delta , RAGE/AGER , advanced glycation end product receptor , advanced glycosylation end product-specific receptor variant 1 , advanced glycosylation end product-specific receptor variant 3 , advanced glycosylation end product-specific receptor variant 4 , advanced glycosylation end product-specific receptor variant 5 , advanced glycosylation end product-specific receptor variant 6 , advanced glycosylation end product-specific receptor variant 7 , advanced glycosylation end product-specific receptor variant 8 , receptor for advanced glycosylation end products , advanced glycation end-products receptor , advanced glycosylation end product-specific receptor variant 2

GENE ID SPECIES
462584 Pan troglodytes
177 Homo sapiens
403168 Canis lupus familiaris
396591 Sus scrofa
280986 Bos taurus
11596 Mus musculus
81722 Rattus norvegicus
100343142 Oryctolagus cuniculus
100726130 Cavia porcellus
101111586 Ovis aries
anti-Advanced Glycosylation End Product-Specific Receptor (AGER) 抗体 精选生产商
您还需要查找其他产品吗?